Petr Jansa

984 total citations
56 papers, 713 citations indexed

About

Petr Jansa is a scholar working on Organic Chemistry, Molecular Biology and Epidemiology. According to data from OpenAlex, Petr Jansa has authored 56 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 21 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Petr Jansa's work include Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and Biochemical and Molecular Research (9 papers). Petr Jansa is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (10 papers), HIV/AIDS drug development and treatment (10 papers) and Biochemical and Molecular Research (9 papers). Petr Jansa collaborates with scholars based in Czechia, United States and Belgium. Petr Jansa's co-authors include Martin Dračínský, Zlatko Janeba, Antonı́n Holý, Ondřej Baszczyňski, Zdeňek Zı́dek, Ivan Votruba, Miloš Buděšı́nský, Eliška Procházková, Martin Lepšı́k and Jan Konvalinka and has published in prestigious journals such as Journal of Medicinal Chemistry, Green Chemistry and Chemistry - A European Journal.

In The Last Decade

Petr Jansa

55 papers receiving 702 citations

Peers

Petr Jansa
Abdalla E. A. Hassan United States
Stanley A. Lang United States
George Fytas Greece
Tasir S. Haque United States
Benjamin A. Horenstein United States
Vinay V. Thakur India
Marija Luić Croatia
Rafael G. da Silva Brazil
Jeffrey Buter Netherlands
Raymond P. Panzica United States
Abdalla E. A. Hassan United States
Petr Jansa
Citations per year, relative to Petr Jansa Petr Jansa (= 1×) peers Abdalla E. A. Hassan

Countries citing papers authored by Petr Jansa

Since Specialization
Citations

This map shows the geographic impact of Petr Jansa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petr Jansa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petr Jansa more than expected).

Fields of papers citing papers by Petr Jansa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petr Jansa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petr Jansa. The network helps show where Petr Jansa may publish in the future.

Co-authorship network of co-authors of Petr Jansa

This figure shows the co-authorship network connecting the top 25 collaborators of Petr Jansa. A scholar is included among the top collaborators of Petr Jansa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petr Jansa. Petr Jansa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrao, Ryan, Joshua A. Kaplan, Shawn S. Badal, et al.. (2025). The Discovery of GS-1291269: A Neutral Ketohexokinase (KHK) Inhibitor with an Unusual Thietane Amine Functional Group. Journal of Medicinal Chemistry. 69(1). 501–516.
2.
Baszczyňski, Ondřej, Martin Kaiser, Martin Dračínský, et al.. (2023). Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties. Journal of Medicinal Chemistry. 66(3). 1761–1777. 11 indexed citations
3.
Dejmek, Milan, Ondřej Baszczyňski, David Šaman, et al.. (2019). Synthesis and anti-human immunodeficiency virus activity of substituted (o,o-difluorophenyl)-linked-pyrimidines as potent non‐nucleoside reverse transcriptase inhibitors. Antiviral chemistry & chemotherapy. 27. 2664945753–2664945753. 6 indexed citations
4.
Jansa, Petr, et al.. (2018). Influence of the C-5 substitution in polysubstituted pyrimidines on inhibition of prostaglandin E2 production. European Journal of Medicinal Chemistry. 156. 295–301. 10 indexed citations
5.
Česnek, Michal, Petr Jansa, Martin Dračínský, et al.. (2018). Nucleobase Modified Adefovir (PMEA) Analogues as Potent and Selective Inhibitors of Adenylate Cyclases from Bordetella pertussis and Bacillus anthracis. ChemMedChem. 13(17). 1779–1796. 7 indexed citations
6.
Baszczyňski, Ondřej, Martin Kaiser, Michal Česnek, et al.. (2018). Xanthine-based acyclic nucleoside phosphonates with potent antiviral activity against varicella-zoster virus and human cytomegalovirus. Antiviral chemistry & chemotherapy. 26. 2663932538–2663932538. 4 indexed citations
7.
Jansa, Petr, et al.. (2017). Polysubstituted 4,6-bis(hetero)arylpyrimidines as dual inhibitors of nitric oxide and prostaglandin E 2 production. Nitric Oxide. 67. 53–57. 5 indexed citations
8.
Šimon, Petr, Ondřej Baszczyňski, David Šaman, et al.. (2016). Novel (2,6-difluorophenyl)(2-(phenylamino)pyrimidin-4-yl)methanones with restricted conformation as potent non-nucleoside reverse transcriptase inhibitors against HIV-1. European Journal of Medicinal Chemistry. 122. 185–195. 14 indexed citations
9.
Zı́dek, Zdeňek, et al.. (2016). Dual inhibition of nitric oxide and prostaglandin E 2 production by polysubstituted 2-aminopyrimidines. Nitric Oxide. 57. 48–56. 7 indexed citations
10.
Česnek, Michal, Petr Jansa, Helena Mertlíková‐Kaiserová, et al.. (2015). Bisamidate Prodrugs of 2‐Substituted 9‐[2‐(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis. ChemMedChem. 10(8). 1351–1364. 19 indexed citations
11.
Nachtigallová, Dana, Haresh Ajani, Petr Jansa, et al.. (2014). Malonate-based inhibitors of mammalian serine racemase: Kinetic characterization and structure-based computational study. European Journal of Medicinal Chemistry. 89. 189–197. 45 indexed citations
12.
Blažek, Jiří, Petr Jansa, Ondřej Baszczyňski, et al.. (2012). An enzymatic glycosylation of nucleoside analogues using β-galactosidase from Escherichia coli. Bioorganic & Medicinal Chemistry. 20(9). 3111–3118. 8 indexed citations
13.
Kaiser, Martin, Petr Jansa, Martin Dračínský, & Zlatko Janeba. (2012). A novel type of acyclic nucleoside phosphonates derived from 2-(phosphonomethoxy)propanoic acid. Tetrahedron. 68(21). 4003–4012. 8 indexed citations
14.
Procházková, Eliška, et al.. (2012). Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening. Bioorganic & Medicinal Chemistry Letters. 22(20). 6405–6409. 7 indexed citations
15.
Baszczyňski, Ondřej, Petr Jansa, Martin Dračínský, et al.. (2011). Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Bioorganic & Medicinal Chemistry. 19(7). 2114–2124. 23 indexed citations
16.
Ettrich, Rüdiger, et al.. (2011). Inhibition of Human Serine Racemase, an Emerging Target for Medicinal Chemistry. Current Drug Targets. 12(7). 1037–1055. 43 indexed citations
17.
Procházková, Eliška, Petr Jansa, Martin Dračínský, Antonı́n Holý, & Helena Mertlíková‐Kaiserová. (2011). Determination of the antioxidative activity of substituted 5-aminopyrimidines. Free Radical Research. 46(1). 61–67. 5 indexed citations
18.
Dračínský, Martin, Petr Jansa, & Petr Bouř. (2011). Computational and Experimental Evidence of Through‐Space NMR Spectroscopic J Coupling of Hydrogen Atoms. Chemistry - A European Journal. 18(3). 981–986. 27 indexed citations
19.
Jansa, Petr, Ondřej Baszczyňski, Martin Dračínský, et al.. (2011). A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities. European Journal of Medicinal Chemistry. 46(9). 3748–3754. 55 indexed citations
20.
Macháček, V., Petr Jansa, & V. Bertolasi. (2006). Derivatives of 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid. Heterocycles. 68(1). 59–59. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdalla E. A. Hassan Breakdown of academic impact, for papers by Stanley A. Lang Breakdown of academic impact, for papers by George Fytas Breakdown of academic impact, for papers by Tasir S. Haque Breakdown of academic impact, for papers by Benjamin A. Horenstein Breakdown of academic impact, for papers by Vinay V. Thakur Breakdown of academic impact, for papers by Marija Luić Breakdown of academic impact, for papers by Rafael G. da Silva Breakdown of academic impact, for papers by Jeffrey Buter Breakdown of academic impact, for papers by Raymond P. Panzica
Rankless by CCL
2026